Literature DB >> 20047979

Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.

Alejandro Balsa1, Eugenio de Miguel, Concepción Castillo, Diana Peiteado, Emilio Martín-Mola.   

Abstract

OBJECTIVE: To investigate the accuracy of composite scores in classifying RA patients who are in remission using the absence of inflammatory activity detected by ultrasound (US) as a gold standard.
METHODS: Ninety-seven RA patients who were classified by their rheumatologists as being in remission were studied. Disease activity was assessed by the DAS-28 and simplified disease activity index (SDAI). US examination was performed in mode B and power Doppler (PD) in 42 joints.
RESULTS: Synovial hypertrophy (SH) and PD were present in 92 (94.8%) and 41 (42.3%) patients. If we consider 'remission' to be the absence of joints with PD signal, no differences were found by DAS-28 between patients in remission and those not in remission, although differences were present by SDAI. We then calculated the sensitivity (S), specificity (Sp) and positive likelihood ratio (LR) of different SDAI cut-off points to predict absence of PD signal. SDAI < 5 had an S of 65% (95% CI 52, 76), Sp of 55% (95% CI 39, 69) and LR of 1.45 (95% CI 0.98, 2.15), whereas SDAI < 3.3 had an S of 57% (95% CI 44, 69), Sp of 74% (95% CI 58, 85) and LR of 2.24 (95% CI 1.25, 4.01).
CONCLUSIONS: Our results suggest that the SDAI classification of remission is closer to the concept of an absence of inflammatory activity, as defined by the absence of positive PD signal by US.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047979     DOI: 10.1093/rheumatology/kep442

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  32 in total

Review 1.  My treatment approach to rheumatoid arthritis.

Authors:  John M Davis; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

Review 2.  Ultrasonography in inflammatory rheumatic disease: an overview.

Authors:  Michael Schirmer; Christina Duftner; Wolfgang A Schmidt; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

3.  SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.

Authors:  Emilce Edith Schneeberger; Natalia Zamora; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

Review 4.  Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Nat Rev Rheumatol       Date:  2015-02-17       Impact factor: 20.543

5.  Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

Authors:  Iustina Janta; Lara Valor; Inmaculada De la Torre; Lina Martínez-Estupiñán; Juan Carlos Nieto; Juan Gabriel Ovalles-Bonilla; Julia Martínez-Barrio; Natalia Bello; Michelle Hinojosa; María Montoro; Carlos Manuel González; Javier López-Longo; Indalecio Monteagudo; Luis Carreño; Esperanza Naredo
Journal:  Rheumatol Int       Date:  2015-12-28       Impact factor: 2.631

Review 6.  Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis--a systematic review of the literature.

Authors:  David F Ten Cate; Jolanda J Luime; Nanno Swen; Andreas H Gerards; Mike H De Jager; Natalja M Basoski; Johanna M W Hazes; Cees J Haagsma; Johannes W G Jacobs
Journal:  Arthritis Res Ther       Date:  2013-01-08       Impact factor: 5.156

Review 7.  Outcome assessments in rheumatoid arthritis.

Authors:  Katarzyna Gilek-Seibert; Kara Prescott; Salahuddin Kazi
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

8.  A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.

Authors:  Eugenio de Miguel; Angela Pecondón-Español; Manuel Castaño-Sánchez; Alfonso Corrales; Ricardo Gutierrez-Polo; Manuel Rodriguez-Gomez; Jose A Pinto-Tasende; Jose L Rivas; José Ivorra-Cortés
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

Review 9.  Remission in rheumatoid arthritis.

Authors:  Rania M Shammas; Veena K Ranganath; Harold E Paulus
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

10.  American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors:  David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal:  Arthritis Rheum       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.